Search Results

There are 198160 results for: content related to: Infliximab-related malignant melanoma and cranial nerves IX and XII palsy secondary to IFN-α2b therapy

  1. Growth inhibitory effects of pegylated IFN α-2b on human liver cancer cells in vitro and in vivo

    Liver International

    Volume 26, Issue 8, October 2006, Pages: 964–975, Hirohisa Yano, Sachiko Ogasawara, Seiya Momosaki, Jun Akiba, Sakiko Kojiro, Suguru Fukahori, Hironori Ishizaki, Keitaro Kuratomi, Yuji Basaki, Shinji Oie, Michihiko Kuwano and Masamichi Kojiro

    Version of Record online : 10 AUG 2006, DOI: 10.1111/j.1478-3231.2006.01321.x

  2. Optimization of an induction strategy for improving interferon-α2b production in the periplasm of Escherichia coli using response surface methodology

    Biotechnology and Applied Biochemistry

    Volume 56, Issue 4, August 2010, Pages: 141–150, Siti Nor Ani Azaman, Nagasundara Ramanan Ramakrishnan, Joo Shun Tan, Raha Abdul Rahim, Mohd Puad Abdullah and Arbakariya B. Ariff

    Version of Record online : 23 DEC 2010, DOI: 10.1042/BA20100104

  3. You have full text access to this Open Access content
    Field production and functional evaluation of chloroplast-derived interferon-α2b

    Plant Biotechnology Journal

    Volume 5, Issue 4, July 2007, Pages: 511–525, Philip A. Arlen, Regina Falconer, Sri Cherukumilli, Amy Cole, Alexander M. Cole, Karen K. Oishi and Henry Daniell

    Version of Record online : 9 MAY 2007, DOI: 10.1111/j.1467-7652.2007.00258.x

  4. You have free access to this content
    Identification of a linear epitope of interferon-α2b recognized by neutralizing monoclonal antibodies

    European Journal of Biochemistry

    Volume 265, Issue 1, October (I) 1999, Pages: 11–19, Viviana C. Blank, Aída Sterin-Prync, Lilia Retegui, Alejandro Vidal, Marcelo Criscuolo and Leonor P. Roguin

    Version of Record online : 25 DEC 2001, DOI: 10.1046/j.1432-1327.1999.00554.x

  5. You have free access to this content
    Interferon α-induced apoptosis on rat preneoplastic liver is mediated by hepatocytic transforming growth factor β1

    Hepatology

    Volume 40, Issue 2, August 2004, Pages: 394–402, María de Luján Alvarez, María Teresa Ronco, J. Elena Ochoa, Juan A. Monti, Cristina E. Carnovale, Gerardo B. Pisani, María Cristina Lugano and María Cristina Carrillo

    Version of Record online : 13 AUG 2004, DOI: 10.1002/hep.20307

  6. Characterization of the self-association of human interferon-α2b, albinterferon-α2b, and pegasys

    Journal of Pharmaceutical Sciences

    Volume 101, Issue 1, January 2012, Pages: 68–80, Yiming Li, Walter F. Stafford, Mark Hesselberg, David Hayes, Zhuchun Wu and Michael Byrne

    Version of Record online : 4 OCT 2011, DOI: 10.1002/jps.22751

  7. You have free access to this content
    Temozolomide in combination with interferon α-2b in patients with metastatic melanoma

    Cancer

    Volume 97, Issue 1, 1 January 2003, Pages: 121–127, Sanjiv S. Agarwala and John M. Kirkwood

    Version of Record online : 18 DEC 2002, DOI: 10.1002/cncr.11041

  8. Effects of interferon-α2b on keloid treatment with triamcinolone acetonide intralesional injection

    International Journal of Dermatology

    Volume 47, Issue 2, February 2008, Pages: 183–186, June Hyunkyung Lee, Seong Eon Kim and Ai-Young Lee

    Version of Record online : 15 JAN 2008, DOI: 10.1111/j.1365-4632.2008.03426.x

  9. You have free access to this content
    Suitable experimental conditions are required to characterize interferon-α2b synthetic peptides

    European Journal of Biochemistry

    Volume 267, Issue 18, September 2000, Pages: 5711–5716, Viviana C. Blank, Clara Peña and Leonor P. Roguin

    Version of Record online : 25 DEC 2001, DOI: 10.1046/j.1432-1327.2000.01618.x

  10. Anti-interferon-α neutralizing antibody is associated with nonresponse to pegylated interferon-α plus ribavirin in chronic hepatitis C

    Journal of Viral Hepatitis

    Volume 19, Issue 10, October 2012, Pages: 694–703, F. Matsuda, Y. Torii, H. Enomoto, C. Kuga, N. Aizawa, Y. Iwata, M. Saito, H. Imanishi, S. Shimomura, H. Nakamura, H. Tanaka, H. Iijima, H. Tsutsui, Y. Tanaka and S. Nishiguchi

    Version of Record online : 29 MAY 2012, DOI: 10.1111/j.1365-2893.2012.01598.x

  11. FoxO3a modulation and promotion of apoptosis by interferon-α2b in rat preneoplastic liver

    Liver International

    Volume 34, Issue 10, November 2014, Pages: 1566–1577, Juan P. Parody, Maria P. Ceballos, Ariel D. Quiroga, Daniel E. Frances, Cristina E. Carnovale, Gerardo B. Pisani, Maria L. Alvarez and Maria C. Carrillo

    Version of Record online : 23 DEC 2013, DOI: 10.1111/liv.12421

  12. Pegylated α-interferon-2a plus ribavirin compared with pegylated α-interferon-2b plus ribavirin for initial treatment of chronic hepatitis C virus: Prospective, non-randomized study

    Journal of Gastroenterology and Hepatology

    Volume 23, Issue 6, June 2008, Pages: 861–866, Amparo Escudero, Felicidad Rodríguez, Miguel A Serra, Juan A Del Olmo, Francisco Montes and José M Rodrigo

    Version of Record online : 19 APR 2008, DOI: 10.1111/j.1440-1746.2008.05397.x

  13. You have free access to this content
    Reciprocal interference between insulin and interferon-alpha signaling in hepatic cells: A vicious circle of clinical significance?

    Hepatology

    Volume 54, Issue 2, August 2011, Pages: 484–494, Lisa Franceschini, Stefano Realdon, Moira Marcolongo, Silvia Mirandola, Gladis Bortoletto and Alfredo Alberti

    Version of Record online : 23 JUN 2011, DOI: 10.1002/hep.24394

  14. Clinical and Immunologic Basis of Interferon Therapy in Melanoma

    Annals of the New York Academy of Sciences

    Volume 1182, Issue 1, December 2009, Pages: 47–57, Ahmad A. Tarhini and John M. Kirkwood

    Version of Record online : 10 DEC 2009, DOI: 10.1111/j.1749-6632.2009.05073.x

    Corrected by:

    Corrigendum for Ann. N.Y. Acad. Sci. 2009. 1182: 47–57

    Vol. 1267, Issue 1, 117, Version of Record online: 6 SEP 2012

  15. Advantage of IFN-β/α2b same-day administration for ribavirin-intolerant patients with chronic hepatitis C

    Hepatology Research

    Volume 40, Issue 3, March 2010, Pages: 261–268, Eiichi Tomita, Kazuki Ando, Jun-ichi Sugihara, Youichi Nishigaki, Tetsuya Yamada, Ryoko Ando, Masao Takemura and Mitsuru Seishima

    Version of Record online : 11 JAN 2010, DOI: 10.1111/j.1872-034X.2009.00602.x

  16. You have free access to this content
    Disruption of Pichia pastoris PMR1 gene decreases its folding capacity on human serum albumin and interferon-α2b fusion protein

    Yeast

    Volume 25, Issue 4, April 2008, Pages: 279–286, Hong Liang Zhao, Chong Xue, Yang Wang, Qing Fen Duan, Xiang Hua Xiong, Xue Qin Yao and Zhi Min Liu

    Version of Record online : 18 MAR 2008, DOI: 10.1002/yea.1589

  17. Purification and conformational properties of a human interferon α2b produced in Escherichia coli

    Biotechnology and Applied Biochemistry

    Volume 33, Issue 3, June 2001, Pages: 173–182, Alejandro Beldarraín, Yai Cruz, Oscar Cruz, Monica Navarro and Miriela Gil

    Version of Record online : 23 DEC 2010, DOI: 10.1042/BA20010001

  18. Temozolomide and interferon α2b in metastatic melanoma stage IV

    British Journal of Dermatology

    Volume 151, Issue 1, July 2004, Pages: 91–98, E. Richtig, R. Hofmann-Wellenhof, H. Pehamberger, CH. Forstinger, K. Wolff, P. Mischer, J. Raml, P. Fritsch, B. Zelger, G. Ratzinger, J. Koller, A. Lang, K. Konrad, E. Kindermann-Glebowski, A. Seeber, A. Steiner, R. Fialla, W. Pachinger, C. Kos, G. Klein, H. Kehrer, H. Kerl, H. Ulmer and J. Smolle

    Version of Record online : 9 JUL 2004, DOI: 10.1111/j.1365-2133.2004.06019.x

  19. The use of different Peg-interferon α-2b regimens plus ribavirin in HCV-1b-infected patients after rapid virological response does not affect the achievement of sustained virological response

    Journal of Viral Hepatitis

    Volume 15, Issue 4, April 2008, Pages: 300–304, N. Napoli, G. Giannelli, A. Antonaci and S. Antonaci

    Version of Record online : 9 DEC 2007, DOI: 10.1111/j.1365-2893.2007.00944.x

  20. Comparative effects of interferon alpha-2b and pegylated interferon alpha-2b on menstrual cycles and ovarian hormones in cynomolgus monkeys

    Birth Defects Research Part B: Developmental and Reproductive Toxicology

    Volume 86, Issue 1, February 2009, Pages: 29–39, Brian P. Enright, David R. Compton, Nathaniel Collins, Thomas Davis and Barry S. McIntyre

    Version of Record online : 25 FEB 2009, DOI: 10.1002/bdrb.20179